Key facts
- It has raised $44.4M across 2 recorded rounds; the latest was Early Stage VC ($10.2M) in Jul 2020.
- Notable investors include Plug and Play Tech Center, Google for Startups, European Bank for Reconstruction and Development, PharmStars, One Peak Partners — 21 tracked in total.
- Infermedica has filed 2 Form Ds with the SEC since 2019, most recently Jul 2020 ($10.2M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Infermedica
Funding rounds
2 roundsAbout Infermedica
Developer of a symptom checker platform designed to guide every individual to a preliminary medical diagnosis. The company's platform assists with inaccurate patient triage, symptom analysis, and exchange of information with clinical staff for further diagnostic assistance to ask questions and unmask patients' conditions, enabling healthcare companies to increase healthcare accessibility, minimize the rate of misdiagnosis, and streamline costs of providing quality care.
- Sector
- Healthcare
- HQ
- Wroclaw, Poland
- Founded
- 2012
- Employees
- 201
- Website
- infermedica.com/
- Ownership
- Privately Held (backing)
Infermedica doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Infermedica shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Infermedica in its N-PORT filings yet. We sweep new filings monthly.